 |
Agrawal Yash N; Fernandez-Martinez Aranzazu; Gil-Gil Miguel; Zielinski Christoph; Ruiz-Borrego Manuel; Ciruelos Eva Maria; Munoz Montserrat; Margeli Mireia; Bermejo Begona; Anton Antonio; Kahán Zsuzsanna; Csöszi Tibor; Alonso-Romero Jose Luis; Garcia-Saenz Jose Angel; Sanchez-Rovira Pedro; Alvarez Elena; Chacon Jose Ignacio; Gonzalez-Santiago Santiago; Rodriguez Cesar A; Servitja Sonia; Pfefferle Adam D; Herranz Jesus; Liu Yuan; Carey Lisa A; Romero-Camarero Isabel; Caballero Rosalia; Guerrero-Zotano Angel; Perou Charles M; Martin Miguel:
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.
JCO PRECISION ONCOLOGY, 9.
ISSN 2473-4284
(2025)
Martin Miguel; Zielinski Christoph; Ruiz-Borrego Manuel; Carrasco Eva; Ciruelos Eva M.; Munoz Montserrat; Bermejo Begona; Margeli Mireia; Csoszi Tibor; Anton Antonio; Turner Nicholas; Casas Maria I; Morales Serafin; Alba Emilio; Calvo Lourdes; De La Haba-Rodriguez Juan; Ramos Manuel; Murillo Laura; Santaballa Ana; Alonso-Romero Jose L.; Sanchez-Rovira Pedro; Corsaro Massimo; Huang Xin; Thallinger Christiane; Kahán Zsuzsanna; Gil-Gil Miguel:
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
EUROPEAN JOURNAL OF CANCER, 168.
pp. 12-24.
ISSN 0959-8049
(2022)
![[Fel]](/style/images/multi_up.png)
Vissza
